PEPTIDE RESEARCH TOPIC

Selank Research Peptide

Explore Selank research, peptide identity, neuronal and behavioral experiments, human-evidence limitations, and comparisons with Semax.

TOPIC OVERVIEW

About Selank

Identity and names

Selank is a synthetic peptide related to the tuftsin sequence; Selank acetate describes a salt preparation. Selank and Semax are distinct compounds.

Compound type

It is a heptapeptide investigated in neurobiological and behavioral research. Formulation and administration route matter when comparing evidence.

Mechanism

Experimental work examines neurotransmission-related gene expression and behavioral responses. A laboratory signal is not proof of a clinical anxiety benefit.

Research focus and evidence

Published evidence includes cell and animal studies. Study design and human clinical evidence should be evaluated separately from marketing descriptions.

Regulatory status and limits

FDA notes missing important human-safety information for Selank acetate. Approval or clinical use in another jurisdiction cannot be generalized to U.S. products.

Topics covered
  • Selank and Semax distinctions
  • GABA-related experiments
  • behavioral models
  • human evidence and limits
Common names and related terms: Selank, Selank acetate, TP-7
RESEARCH SUMMARY

What Is Selank?

LAST VERIFIEDOctober 7, 2026

In IMR-32 cells, Selank alone did not change the measured GABAergic gene-expression levels, while combinations with GABA or olanzapine altered responses. These laboratory findings are not patient outcomes or proof of a clinical mechanism. Selank GABAergic gene-expression study

FDA identifies important gaps in human-safety information for Selank acetate. Experimental activity does not resolve the safety of a particular preparation or administration route. FDA, Selank acetate safety information

EVIDENCE PROFILE

Selank Research Evidence

A concise view of registered clinical research, PubMed-indexed literature, evidence stage, and important limitations.

LAST VERIFIEDOctober 7, 2026
Registered records0
Active studies0
Completed studies0
PubMed records68
Compound typeIt is a heptapeptide investigated in neurobiological and behavioral research. Formulation and administration route matter when comparing evidence.
AliasesSelank, Selank acetate, TP-7
Evidence stagePublished evidence includes cell and animal studies. Study design and human clinical evidence should be evaluated separately from marketing descriptions.
U.S. regulatory contextFDA notes missing important human-safety information for Selank acetate. Approval or clinical use in another jurisdiction cannot be generalized to U.S. products.
CLINICAL REGISTRY

Selected registered research

No matching intervention record was found in ClinicalTrials.gov during this verification. This does not mean that no research exists.

INDEXED LITERATURE

Selected PubMed records

PMID 282931902017 · Frontiers in pharmacology

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.

PMID 414902002026 Jan 1 · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

PMID 323423182020 Jan · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

Functional Connectomic Approach to Studying Selank and Semax Effects.

How to interpret this profile

Registry and publication counts describe discoverable records, not proof of effectiveness or safety. Study design, compound identity, population, endpoints, and regulatory context must be reviewed individually.

Primary sources: ClinicalTrials.gov (defined search) · PubMed (defined query)Checked October 7, 2026. Counts include interventional registry records with an explicit matching intervention name or alias; broad search results, biomarker-only observations, and unrelated compounds are excluded. Active includes recruiting, not yet recruiting, active not recruiting, and enrolling by invitation. PubMed is the linked title/abstract query count, not a number of clinical trials or a measure of evidence quality.

Displayed records are selected for relevance and recency; the page does not reproduce the complete source databases.

START HERE

Essential Selank guides

SELANK KNOWLEDGE ARTICLESPage 1 of 2
01
KNOWLEDGE ARTICLE

Selank Nasal Spray vs Injection: Key Differences

Selank nasal spray vs injection: compare absorption, onset, convenience, and safety in research settings. Learn how each route differs and what to consider.

↗
03
KNOWLEDGE ARTICLE

Adalank vs Selank: Key Differences Explained

Adalank vs Selank compared: research evidence, chemical structure, typical routes, and regulatory status, plus what US researchers should verify before buying.

↗
05
KNOWLEDGE ARTICLE

Selank Withdrawal: What Research Actually Shows

Selank withdrawal is not a documented clinical syndrome, but users report rebound anxiety after stopping. Here's what research says about tapering and safety.

↗
06
KNOWLEDGE ARTICLE

Selank for ADHD: What Research Actually Shows

Selank for ADHD is not an approved treatment. Learn what research says about selank, its effects on focus and anxiety, dosing, safety, and legal status.

↗
07
KNOWLEDGE ARTICLE

Selank Nasal Spray Side Effects: What to Know

Selank nasal spray side effects may include irritation, headache, and fatigue. Learn what research and user reports say about selank risks and safety.

↗
08
KNOWLEDGE ARTICLE

Is Selank FDA Approved? US Legal & Safety Facts

Is Selank FDA approved? No — it's an unapproved new drug in the US. Here's what that means for legality, sourcing, safety, and research use today.

↗
09
KNOWLEDGE ARTICLE

Selank Reconstitution: Nasal Spray Guide

A practical selank reconstitution guide covering bacteriostatic water ratios, 5 mg and 10 mg dosing math, nasal spray steps, storage, and safety.

↗
10
KNOWLEDGE ARTICLE

N-Acetyl Selank Nasal Spray: Research Guide

N-acetyl selank nasal spray explained: how this modified selank peptide differs from standard selank, delivery routes, reported side effects, and legal status.

↗
11
KNOWLEDGE ARTICLE

How Long for Selank to Work? Onset Timeline

Wondering how long for Selank to work? Most users notice calm within 15-30 minutes, while anxiety relief and focus benefits build over 1-3 weeks of daily use.

↗
12
KNOWLEDGE ARTICLE

Where to Buy Selank: Safe Sources & What to Know

Wondering where to buy selank? Learn about legitimate research chemical vendors, nasal spray options, legal status, and safety checks before you purchase.

↗
16
KNOWLEDGE ARTICLE

Selank Half-Life: How Long Does Selank Last?

Selank half-life is often cited as about 0.3 hours, but effects can last longer. Learn what research says about how long selank lasts and key safety facts.

↗
17
KNOWLEDGE ARTICLE

Selank Dosage Chart: Nasal Spray vs Injection

A selank dosage chart covering nasal spray and injection protocols, typical daily amounts, and 5 mg and 10 mg vial math for laboratory research use.

↗
19
KNOWLEDGE ARTICLE

Selank vs N-Acetyl Selank: Key Differences

Selank vs n-acetyl selank comes down to stability, potency, and dose. Compare their makeup, research dosing, and lab handling before you choose.

↗